Showing results (981-990 of 6,317) with videos related to

Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|June 10, 2014
Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trialD Elleri, G Maltoni, J M Allen, et al.
Diabetes, Obesity & Metabolism|October 2, 2012
Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulinK Tertti, U Ekblad, P Koskinen, et al.
Diabetes, Obesity & Metabolism|June 25, 2014
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetesP D Home, G B Bolli, C Mathieu, et al.
Diabetes, Obesity & Metabolism|June 26, 2014
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitisM J Armstrong, J M Hazlehurst, D Hull, et al.
Diabetes, Obesity & Metabolism|February 20, 2015
Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetesG Pacini, A Mari, P Fouqueray, et al.
Diabetes, Obesity & Metabolism|February 20, 2015
Effects of sitagliptin on counter-regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double-blind placebo-controlled crossover studyJ E Schopman, J B L Hoekstra, B M Frier, et al.
Diabetes, Obesity & Metabolism|June 19, 2014
Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitusS Sha, D Polidori, T Heise, et al.
Diabetes, Obesity & Metabolism|April 2, 2015
Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trialS Ross, C Thamer, J Cescutti, et al.
Diabetes, Obesity & Metabolism|April 8, 2015
One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extensionM C Riddle, H Yki-Järvinen, G B Bolli, et al.
Diabetes, Obesity & Metabolism|August 4, 2020
Efficacy and safety of polyethylene glycol loxenatide as add-on to metformin in patients with type 2 diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 3b trialFei Gao, Xiaofeng Lv, Zhaohui Mo, et al.
Pageof 632